Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | GMAB | BMY | AMGN | MRNA | GILD |
Company | Genmab A/S ADR | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 27.66 | 47.39 | 273.45 | 107.43 | 67.47 |
High | 27.80 | 47.50 | 274.35 | 108.23 | 67.90 |
Low | 27.51 | 44.37 | 267.24 | 103.52 | 65.26 |
Last | 27.65 | 44.63 | 270.07 | 105.80 | 65.48 |
Change | -0.82 | -4.23 | -2.94 | -3.05 | -1.60 |
% Change | -2.88% | -8.66% | -1.08% | -2.80% | -2.39% |
Volume | 225,855 | 29,273,842 | 784,484 | 1,687,424 | 6,473,987 |
20-Day Average Volume | 389,154 | 11,999,422 | 2,096,903 | 3,079,688 | 6,394,310 |
Previous Close | 28.47 | 48.86 | 273.01 | 108.85 | 67.08 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 29.29 | 49.93 | 270.67 | 104.93 | 68.68 |
20-Day Raw Stochastic | 4.28% | 1.19% | 28.80% | 41.56% | 0.06% |
20-Day Relative Strength | 38.60% | 27.87% | 44.23% | 51.48% | 28.33% |
Weighted Alpha | -32.47 | -35.19 | +8.74 | -12.94 | -23.72 |
Today's Opinion | 100% Sell | 88% Sell | 72% Sell | 88% Buy | 100% Sell |
Previous Opinion | 88% Sell | 88% Sell | 40% Sell | 88% Buy | 100% Sell |
Last Month's Opinion | 24% Sell | 8% Sell | 24% Buy | 72% Buy | 88% Sell |
Performance | |||||
5-Days | |||||
%Chg | -2.40% since 04/18/24 | -7.89% since 04/18/24 | +2.27% since 04/18/24 | +2.79% since 04/18/24 | -1.34% since 04/18/24 |
Low | 27.52 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 99.30 on 04/22/24 | 65.27 on 04/25/24 |
High | 29.21 on 04/22/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 111.29 on 04/24/24 | 67.78 on 04/25/24 |
1-Month | |||||
%Chg | -7.77% since 03/25/24 | -14.85% since 03/25/24 | -4.31% since 03/25/24 | -5.01% since 03/25/24 | -10.06% since 03/25/24 |
Low | 27.52 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 97.00 on 04/03/24 | 65.27 on 04/25/24 |
High | 31.02 on 03/26/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 115.89 on 04/09/24 | 73.87 on 03/28/24 |
3-Month | |||||
%Chg | -1.78% since 01/25/24 | -10.32% since 01/25/24 | -13.39% since 01/25/24 | +1.99% since 01/25/24 | -18.64% since 01/25/24 |
Low | 26.32 on 02/13/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 84.06 on 02/13/24 | 65.27 on 04/25/24 |
High | 31.88 on 03/13/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 115.89 on 04/09/24 | 80.51 on 01/26/24 |
6-Month | |||||
%Chg | -4.82% since 10/25/23 | -21.41% since 10/25/23 | -1.27% since 10/25/23 | +36.60% since 10/25/23 | -16.73% since 10/25/23 |
Low | 26.32 on 02/13/24 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 62.55 on 11/02/23 | 65.27 on 04/25/24 |
High | 32.89 on 11/17/23 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 |
Key Statistics | |||||
Market Capitalization, $K | 18,825,218 | 99,027,448 | 146,436,016 | 41,676,488 | 83,519,768 |
Shares Outstanding, K | 661,230 | 2,026,759 | 536,376 | 382,880 | 1,245,077 |
Annual Sales | 2,392,030,000 | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 |
Annual Net Income | 631,910,000 | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 |
Last Quarter Sales | 674,810,000 | 11,477,000,000 | 8,196,000,000 | 2,811,000,000 | 7,114,000,000 |
Last Quarter Net Income | 90,250,000 | 1,762,000,000 | 767,000,000 | 217,000,000 | 1,429,000,000 |
60-Month Beta | 0.99 | 0.39 | 0.58 | 1.62 | 0.19 |
Per-Share Information | |||||
Most Recent Earnings | 0.36 on 02/14/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.55 on 02/22/24 | 1.72 on 02/06/24 |
Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
Ratios | |||||
Price/Earnings ttm | 24.20 | 6.53 | 14.67 | 0.00 | 9.97 |